Author: OurCrowd

[Alloy Therapeutics in Startup News] Alloy Therapeutics announces platform license agreement with Lilly

May 21, 2024 |

Alloy Therapeutics, a biotechnology ecosystem company dedicated to democratizing access to biologics drug discovery platforms and services, announced today a licensing agreement for its murine platforms for fully human antibody discovery with Eli Lilly and Company. The non-exclusive license provides Lilly access to the ATX-Gx™ and ATX-CLC™ mouse platforms and broad rights to use the Alloy platforms for antibody drug discovery and development under this multi-year collaboration. Read...

Read More

[Blue Tree in PR Newswire] Blue Tree’s Proprietary Sugar Reduction System Deemed FDA Food Safe, Proceeds to Market in U.S.

May 20, 2024 |

TEL AVIV, Israel, May 20, 2024 /PRNewswire/ — Blue Tree Technologies Ltd., an Israeli-based food tech startup, has obtained self-affirmed FDA food safe status for its proprietary sugar reduction technology and system, in accordance with the requirements laid out by the U.S. Food and Drug Administration (FDA) for food and food contact materials. Blue Tree’s proprietary system physically and selectively removes sugar content from natural fruit juice and milk without sacrificing taste. No sugar substitutes. No chemicals. All natural. Read more...

Read More